ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 130 filers reported holding ARCUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,285 | -11.7% | 1,910 | -0.1% | 0.00% | – |
| Q2 2023 | $38,813 | +54.8% | 1,911 | +39.0% | 0.00% | – |
| Q1 2023 | $25,080 | +15.8% | 1,375 | +31.3% | 0.00% | – |
| Q4 2022 | $21,652 | +66.6% | 1,047 | +109.4% | 0.00% | – |
| Q3 2022 | $13,000 | +8.3% | 500 | +6.6% | 0.00% | – |
| Q2 2022 | $12,000 | -33.3% | 469 | -17.4% | 0.00% | – |
| Q1 2022 | $18,000 | +50.0% | 568 | +95.2% | 0.00% | – |
| Q4 2021 | $12,000 | -36.8% | 291 | -46.4% | 0.00% | – |
| Q3 2021 | $19,000 | +533.3% | 543 | +448.5% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 99 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 99 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 99 | +125.0% | 0.00% | – |
| Q2 2020 | $1,000 | -95.7% | 44 | -98.5% | 0.00% | – |
| Q2 2019 | $23,000 | -36.1% | 2,891 | 0.0% | 0.00% | – |
| Q1 2019 | $36,000 | +44.0% | 2,891 | +28.7% | 0.00% | – |
| Q4 2018 | $25,000 | -16.7% | 2,246 | +5.6% | 0.00% | – |
| Q3 2018 | $30,000 | – | 2,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |